1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat

NCT03399526 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Mapracorat (ZK 245186, BAY 86-5319)
DRUG: Prednicarbate 0.25% ointment
DRUG: Clobetasol 0.05% ointment
DRUG: Calcipotriene 0.005% ointment
DRUG: Calcipotriene 0.005%/Betamethasone dipropionate 0.05% ointment

Sponsor

Bayer